ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0283

Genome-wide DNA Methylation Analysis in Lupus Keratinocytes Identifies Differential Methylation of Genes That Regulate Apoptosis

Grace Hile1, Patrick Coit1, Chang Zeng1, Rachael Wasikowski2, Alex Tsoi2, Allison Billi2, Johann Gudjonsson3, Amr Sawalha4 and J. Michelle Kahlenberg5, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Ann ARbor, 3University of Michigan, Ann ArborUniversity of Michigan, 4University of Pittsburgh, Pittsburgh, 5Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2020

Keywords: Apoptosis, skin, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cutaneous lupus erythematous (CLE) is a disfiguring manifestation of systemic LE (SLE), and the pathogenesis remains unclear. However, epidermal regulation of skin inflammation and cell death contribute, potentially in a female-biased manner. Differential DNA methylation is important in the organ-specific manifestations of SLE but has not been studied in the skin. Thus, we explored the genome-wide DNA methylation changes in keratinocytes (KC) to investigate the functional relevance in CLE.

Methods: Eight SLE skin biopsy samples were taken from non-sun-exposed, unaffected skin from participants of the Michigan Lupus Cohort as well as age (+/- 6 years), sex, and ethnicity-matched healthy control subjects. Freshly cultured KC (at passage 2) were used to isolate DNA using DNeasy Blood and Tissue Kit. DNA was bisulfite converted for DNA methylation studies using the EZ DNA Methylation Kit. Genome-wide DNA methylation analysis was performed using the Infinium HumanMethylation450 BeadChip Kit. Differentially methylated loci were mapped to genes or gene regions and subject to gene ontology and pathway analysis using the Database for Annotation, Visualization, and Integrated Discovery (DAVID).

Results: We identified 1443 differentially methylated sites with 924 hypomethylated genes and 519 hypermethylated genes in lupus KC compared to controls. Pathway analysis revealed Hippo signaling as the top canonical pathway associated with the DNA methylation profile of primary lupus KCs. TEA Domain Transcription Factor 1 (TEAD1), a key transcription factor in the Hippo pathway, was significantly hypomethylated in lupus compared to control (Δβ =-0.17, P= 4.36 X 10-9). Further, methylation of LATS1/2, which contributes to inactivation of Hippo pathway effector proteins TAZ and YAP, was significantly increased (Δβ= 0.11, P= 3.82 X 10-4). YAP and TAZ were both hypermethylated (Δβ= 0.11 (P= 1.53 X 10-3) and 0.12 (P= 2.20 X 10-4), respectively), thereby increasing TEAD1 activity.

Conclusion: SLE KCs display methylation changes in the Hippo pathway that may contribute to dysregulated apoptosis, a known feature that contributes to photosensitivity in CLE.  Vestigial like family member 3 (VGLL3) has recently been identified as a putative transcription factor and master orchestrator of sex bias in autoimmune diseases, including SLE and CLE. Importantly, studies have shown VGLL3 operates through TEAD1 in other cell types and may be a key upstream regulator in the skin. Overall, these results suggest that differential methylation in KC may underlie dysregulated apoptosis and female bias of CLE.


Disclosure: G. Hile, None; P. Coit, None; C. Zeng, None; R. Wasikowski, None; A. Tsoi, None; A. Billi, None; J. Gudjonsson, Celgene, 2; A. Sawalha, None; J. Kahlenberg, AstraZeneca, 5, Bristol Myers Squibb, 2, 5, Eli Lilly, 5, Avion Pharma, 5, Celgene, 2.

To cite this abstract in AMA style:

Hile G, Coit P, Zeng C, Wasikowski R, Tsoi A, Billi A, Gudjonsson J, Sawalha A, Kahlenberg J. Genome-wide DNA Methylation Analysis in Lupus Keratinocytes Identifies Differential Methylation of Genes That Regulate Apoptosis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/genome-wide-dna-methylation-analysis-in-lupus-keratinocytes-identifies-differential-methylation-of-genes-that-regulate-apoptosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-dna-methylation-analysis-in-lupus-keratinocytes-identifies-differential-methylation-of-genes-that-regulate-apoptosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology